Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLP vs Placebo in Heart Failure with CKD
NCT01265524Phase 2Completed
- Sponsor
- Sorbent Therapeutics
- Start
- Apr 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) and chronic kidney disease (CKD) comparing CLP with Placebo (2 arms). Primary endpoint: Change in Serum Potassium at 8 weeks. Started Apr 2011; status: completed.
02
Drugs
CLP-1001
03
Conditions
heart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01265524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265524.